From Loss to Loneliness: The Effects of Prolonged Grief in Elderly
Downloads
Introduction: COVID-19 high death tolls have brought about many bereavements all over the world. In this brief report, we aim to describe the effects of traumatic end-of-life experiences causing prolonged grief and loneliness as mediators for psychiatric disorders in the elderly. Case: The patient was a 60-year-old woman with chronic sleep disturbance since her only daughter suddenly passed away after several days of being isolated in the hospital during the COVID-19 pandemic and being hastily buried with the COVID-19 protocols. The patient yearned for her daughter but at the same time also avoided all memories of her daughter. She felt anxious most of the day which escalated to panic attacks requiring visits to the emergency room. Various examinations were carried out with normal results, except for blood pressure. She was diagnosed with prolonged grief, generalized anxiety, post-traumatic stress disorder, and hypertension. Treatments included SSRI, benzodiazepine, antihypertensive medicine, and psychotherapy. Improvements were significant within 9 months of therapy. Discussion: Traumatic end-of-life events may precipitate prolonged grief and loneliness. Bereavement is the most common cause of loneliness in the elderly. Untreated prolonged grief and loneliness generate a loss of sense of self and purpose and are associated with low-grade peripheral inflammation and poor health. The combination of pharmacotherapy and psychotherapy is the most effective treatment which improves the patient’s outcome significantly. Conclusion: Traumatic end-of-life experiences are associated with prolonged grief disorder, poor physical and mental health outcomes, hence the right holistic approach is necessary to improve patient outcomes.
Keywords: Prolonged Grief, Loneliness
Copyright (c) 2024 Julia Dian Christiani Adi Santoso, Hendy Muagiri
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. Copyright of this journal is possession of the Author, by the knowledge of the Editorial Board and Journal Manager, while the moral right of the publication belongs to the author.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The articles are published under a Creative Commons Attribution Share-Alike (CC BY-SA) license. Many research funding bodies prefer the CC BY-SA license because it allows for maximum dissemination and re-use of open access materials. Users are free to share (copy, distribute, and transmit) and remix (adapt) the contribution under this license, including for commercial purposes, as long as they attribute the contribution in the manner specified by the author or licensor.